Antimicrobial consumption surveillance in Uganda: Results from an analysis of national import data for the human health sector, 2018–2021

Background: The surveillance of antimicrobial consumption (AMC) is critical to developing appropriate antimicrobial stewardship interventions. It is a key component of World Health Organization’s (WHO) Global Action Plan on Antimicrobial Resistance and the Uganda Antimicrobial Resistance National Ac...

Full description

Bibliographic Details
Main Authors: Marion Murungi, Helen Byomire Ndagije, Reuben Kiggundu, Diana Nakitto Kesi, JP Waswa, Kalidi Rajab, Mark Barigye, Allan Serwanga, Leonard Manirakiza, Hassan Kasujja, Ddembe Kaweesi, Mohan P. Joshi, Juliet Namugambe, Niranjan Konduri
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Journal of Infection and Public Health
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034123003672
_version_ 1827687011981459456
author Marion Murungi
Helen Byomire Ndagije
Reuben Kiggundu
Diana Nakitto Kesi
JP Waswa
Kalidi Rajab
Mark Barigye
Allan Serwanga
Leonard Manirakiza
Hassan Kasujja
Ddembe Kaweesi
Mohan P. Joshi
Juliet Namugambe
Niranjan Konduri
author_facet Marion Murungi
Helen Byomire Ndagije
Reuben Kiggundu
Diana Nakitto Kesi
JP Waswa
Kalidi Rajab
Mark Barigye
Allan Serwanga
Leonard Manirakiza
Hassan Kasujja
Ddembe Kaweesi
Mohan P. Joshi
Juliet Namugambe
Niranjan Konduri
author_sort Marion Murungi
collection DOAJ
description Background: The surveillance of antimicrobial consumption (AMC) is critical to developing appropriate antimicrobial stewardship interventions. It is a key component of World Health Organization’s (WHO) Global Action Plan on Antimicrobial Resistance and the Uganda Antimicrobial Resistance National Action Plan 2018–2023. Our study’s objective was to determine the national consumption of all antimicrobials. Methods: Data on all imported antimicrobials were retrieved from paper-based records and entered in the web-based National Drug Authority (NDA) management information system from 2021. The import data for the year is a proxy for nationwide consumption because they account for 95% of all medical products. The NDA authorizes all imports to the country regardless of final distribution in the supply chain. The data were analyzed in accordance with WHO Anatomical Therapeutic Chemical codes and defined daily dose (DDD) methodology. We also retrieved consumption data for 2018, 2019, and 2020 that were previously submitted by Uganda to WHO’s Global Antimicrobial Resistance and Use Surveillance System. Results: In 2021, the average DDD per 1000 inhabitants was 29.02 for all antimicrobials; 80.7% of antimicrobials consumed were oral. Penicillins (27.6%) were the most consumed antimicrobial class, followed by sulfonamides and trimethoprim (15.5%). Based on WHO’s Access, Watch, and Reserve (AWaRe) antibiotic classification, 62.91% of AMC was from the access class, with watch class averaging 14.51% in the period 2018–2021. Watch class AMC spiked in 2021 (34.2%) during COVID-19 pandemic compared to 2020 (24.29%). Azithromycin and ciprofloxacin were the most consumed watch class antimicrobials in 2021. Conclusions: The relatively high consumption of injectable antimicrobials and year over year increase in watch class AMC requires urgent stewardship interventions. Further work is needed to establish a system for longitudinal AMC surveillance that is well resourced and funded to overcome the challenges of estimation and provide more accurate data on consumption and use patterns.
first_indexed 2024-03-10T09:26:39Z
format Article
id doaj.art-75c44cd93fc643f2b58c25b176ef2723
institution Directory Open Access Journal
issn 1876-0341
language English
last_indexed 2024-03-10T09:26:39Z
publishDate 2023-12-01
publisher Elsevier
record_format Article
series Journal of Infection and Public Health
spelling doaj.art-75c44cd93fc643f2b58c25b176ef27232023-11-22T04:47:04ZengElsevierJournal of Infection and Public Health1876-03412023-12-01164551Antimicrobial consumption surveillance in Uganda: Results from an analysis of national import data for the human health sector, 2018–2021Marion Murungi0Helen Byomire Ndagije1Reuben Kiggundu2Diana Nakitto Kesi3JP Waswa4Kalidi Rajab5Mark Barigye6Allan Serwanga7Leonard Manirakiza8Hassan Kasujja9Ddembe Kaweesi10Mohan P. Joshi11Juliet Namugambe12Niranjan Konduri13USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Kampala, UgandaNational Drug Authority, Kampala, UgandaUSAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Kampala, UgandaNational Drug Authority, Kampala, UgandaUSAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Kampala, UgandaDepartment of Pharmacy, Makerere University College of Health Sciences, Kampala, UgandaNational Drug Authority, Kampala, UgandaNational Drug Authority, Kampala, UgandaDepartment of Corporate Planning, Uganda National Bureau of Standards, Kampala, UgandaUSAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Kampala, UgandaUSAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Kampala, UgandaUSAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Arlington, VA, USALondon School of Hygiene and Tropical Medicine, London, United KingdomUSAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Arlington, VA, USA; Corresponding author.Background: The surveillance of antimicrobial consumption (AMC) is critical to developing appropriate antimicrobial stewardship interventions. It is a key component of World Health Organization’s (WHO) Global Action Plan on Antimicrobial Resistance and the Uganda Antimicrobial Resistance National Action Plan 2018–2023. Our study’s objective was to determine the national consumption of all antimicrobials. Methods: Data on all imported antimicrobials were retrieved from paper-based records and entered in the web-based National Drug Authority (NDA) management information system from 2021. The import data for the year is a proxy for nationwide consumption because they account for 95% of all medical products. The NDA authorizes all imports to the country regardless of final distribution in the supply chain. The data were analyzed in accordance with WHO Anatomical Therapeutic Chemical codes and defined daily dose (DDD) methodology. We also retrieved consumption data for 2018, 2019, and 2020 that were previously submitted by Uganda to WHO’s Global Antimicrobial Resistance and Use Surveillance System. Results: In 2021, the average DDD per 1000 inhabitants was 29.02 for all antimicrobials; 80.7% of antimicrobials consumed were oral. Penicillins (27.6%) were the most consumed antimicrobial class, followed by sulfonamides and trimethoprim (15.5%). Based on WHO’s Access, Watch, and Reserve (AWaRe) antibiotic classification, 62.91% of AMC was from the access class, with watch class averaging 14.51% in the period 2018–2021. Watch class AMC spiked in 2021 (34.2%) during COVID-19 pandemic compared to 2020 (24.29%). Azithromycin and ciprofloxacin were the most consumed watch class antimicrobials in 2021. Conclusions: The relatively high consumption of injectable antimicrobials and year over year increase in watch class AMC requires urgent stewardship interventions. Further work is needed to establish a system for longitudinal AMC surveillance that is well resourced and funded to overcome the challenges of estimation and provide more accurate data on consumption and use patterns.http://www.sciencedirect.com/science/article/pii/S1876034123003672Antimicrobial consumptionAntibiotic consumptionAntimicrobial use surveillanceAntimicrobial resistanceUgandaDefined daily dose
spellingShingle Marion Murungi
Helen Byomire Ndagije
Reuben Kiggundu
Diana Nakitto Kesi
JP Waswa
Kalidi Rajab
Mark Barigye
Allan Serwanga
Leonard Manirakiza
Hassan Kasujja
Ddembe Kaweesi
Mohan P. Joshi
Juliet Namugambe
Niranjan Konduri
Antimicrobial consumption surveillance in Uganda: Results from an analysis of national import data for the human health sector, 2018–2021
Journal of Infection and Public Health
Antimicrobial consumption
Antibiotic consumption
Antimicrobial use surveillance
Antimicrobial resistance
Uganda
Defined daily dose
title Antimicrobial consumption surveillance in Uganda: Results from an analysis of national import data for the human health sector, 2018–2021
title_full Antimicrobial consumption surveillance in Uganda: Results from an analysis of national import data for the human health sector, 2018–2021
title_fullStr Antimicrobial consumption surveillance in Uganda: Results from an analysis of national import data for the human health sector, 2018–2021
title_full_unstemmed Antimicrobial consumption surveillance in Uganda: Results from an analysis of national import data for the human health sector, 2018–2021
title_short Antimicrobial consumption surveillance in Uganda: Results from an analysis of national import data for the human health sector, 2018–2021
title_sort antimicrobial consumption surveillance in uganda results from an analysis of national import data for the human health sector 2018 2021
topic Antimicrobial consumption
Antibiotic consumption
Antimicrobial use surveillance
Antimicrobial resistance
Uganda
Defined daily dose
url http://www.sciencedirect.com/science/article/pii/S1876034123003672
work_keys_str_mv AT marionmurungi antimicrobialconsumptionsurveillanceinugandaresultsfromananalysisofnationalimportdataforthehumanhealthsector20182021
AT helenbyomirendagije antimicrobialconsumptionsurveillanceinugandaresultsfromananalysisofnationalimportdataforthehumanhealthsector20182021
AT reubenkiggundu antimicrobialconsumptionsurveillanceinugandaresultsfromananalysisofnationalimportdataforthehumanhealthsector20182021
AT diananakittokesi antimicrobialconsumptionsurveillanceinugandaresultsfromananalysisofnationalimportdataforthehumanhealthsector20182021
AT jpwaswa antimicrobialconsumptionsurveillanceinugandaresultsfromananalysisofnationalimportdataforthehumanhealthsector20182021
AT kalidirajab antimicrobialconsumptionsurveillanceinugandaresultsfromananalysisofnationalimportdataforthehumanhealthsector20182021
AT markbarigye antimicrobialconsumptionsurveillanceinugandaresultsfromananalysisofnationalimportdataforthehumanhealthsector20182021
AT allanserwanga antimicrobialconsumptionsurveillanceinugandaresultsfromananalysisofnationalimportdataforthehumanhealthsector20182021
AT leonardmanirakiza antimicrobialconsumptionsurveillanceinugandaresultsfromananalysisofnationalimportdataforthehumanhealthsector20182021
AT hassankasujja antimicrobialconsumptionsurveillanceinugandaresultsfromananalysisofnationalimportdataforthehumanhealthsector20182021
AT ddembekaweesi antimicrobialconsumptionsurveillanceinugandaresultsfromananalysisofnationalimportdataforthehumanhealthsector20182021
AT mohanpjoshi antimicrobialconsumptionsurveillanceinugandaresultsfromananalysisofnationalimportdataforthehumanhealthsector20182021
AT julietnamugambe antimicrobialconsumptionsurveillanceinugandaresultsfromananalysisofnationalimportdataforthehumanhealthsector20182021
AT niranjankonduri antimicrobialconsumptionsurveillanceinugandaresultsfromananalysisofnationalimportdataforthehumanhealthsector20182021